Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy targets deadly brain tumors in early trial

NCT ID NCT04988750

First seen Apr 25, 2026 · Last updated Apr 25, 2026

Summary

This small pilot study tested a new approach for people with recurrent glioblastoma, an aggressive brain cancer that has come back after standard treatment. Seven adults received focused ultrasound together with a second round of radiation therapy. The goal was to see if the combination is safe and can help control the tumor. The study did not aim to cure the disease, but to manage it and improve outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Chang Gung Medical Foundation

    Taoyuan District, 333, Taiwan

Conditions

Explore the condition pages connected to this study.